Although the skin will improve after only one session, it is advised to undergo several Dermapen treatments for further skin rejuvenation
Preclinical studies further suggest that GLP-1RAs may modulate key cytokine pathways implicated in psoriatic disease, including NF-B, IL-6, IL17, and IL23, while small clinical studies have reported improvements in skin disease severity in PsO (37)
Typical lipid changes with GLP-1 therapy include: Total cholesterol reduction: 28% LDL cholesterol reduction: 36% Triglyceride reduction: 1015% HDL cholesterol: minimal change or slight increase These effects vary by agent, dose, population, and treatment duration, as shown in systematic reviews and meta-analyses
Its GLP-1 formulation platform covers sweeteners, fibers, and fortification solutions
Following the same pattern, diarrhea was reported by 23% (non-T2D) vs 19% (T2D) of participants treated with tirzepatide 15 mg